การศึกษาภาพรวมของการใช้แคปซูลยาสมุนไพรซานชีในทางคลินิก
Article Sidebar
Main Article Content
บทคัดย่อ
แคปซูลยาสมุนไพรซานซี เป็นยาสมุนไพรจีนที่ใช้กันทั่วไปในทางคลินิก และสามารถใช้ร่วมกันตัวยาอื่นๆ เพื่อเพิ่มประสิทธิผลการรักษาได้ตามความต้องการในทางคลินิก ปัจจุบันมีการใช้อย่างแพร่หลายในการรักษาโรคหลอดเลือดหัวใจ โรคกระดูกและข้อ และโรคที่เกี่ยวกับระบบเลือด นอกจากนี้ยังสามารถใช้รักษาโรคความดันโลหิตสูง ไขมันในเลือดสูง โรคเบาหวาน โรคตับ และโรคเรื้อรังอื่นๆ ได้อีกด้วย ในบทความนี้เป็นการทบทวนวรรณกรรม โดยเป็นการศึกษาภาพรวมการใช้แคปซูลยาสมุนไพรซานซีทั้งแบบยาเดี่ยวและการจับคู่ยาและศึกษาการประยุกต์ใช้ยาในทางโรค เพื่อเป็นข้อมูลการใช้ยาในการรักษาทางคลินิก
Article Details
References
Zhang J. New progress in research on the pharmacological effects of the traditional Chinese medicine Panax notoginseng. China Health Industry. 2017;14(28):40-1. (in Chinese)
Lu HT. Process preparation and clinical efficacy observation of compound Sanqi capsules. Guide of China Medicine. 2012;10(32):452-3. (in Chinese)
Huang JK, Sun W. 136 cases of orthopedic trauma with compound Sanqi capsules. Sichuan Journal of Traditional Chinese Medicine. 2001;19(1):54-5. (in Chinese)
Wu YL, Li Y, Bai X. Clinical observation on the treatment of 60 cases of coronary heart disease and angina pectoris with compound Sanqi capsules. China Medical Herald. 2009;6(11):74-5. (in Chinese)
Wang CH, Li XH, Zhou SL. Observation on the therapeutic effect of Hongjing Sanqi capsules on ventricular premature beats. Nei Mongol Journal of Traditional Chinese Medicine. 2015;34(11):22-3. (in Chinese)
Xu Y, Dai YP, Li MY. The therapeutic effect of Yanghuo Sanqi capsule on stable angina pectoris in coronary heart disease and its impact on SOD and hs-CRP. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease. 2018;16(7):883-5. (in Chinese)
Dong CX, Yu NN, Cong SM, Zhang SC, Wu N, Jing HY, et al. The therapeutic effect and neuroprotective mechanism of Sanqi Tongshu capsules combined with Xingnao Kaiqiao acupuncture in the treatment of acute cerebral infarction. Chinese Traditional Patent Medicine. 2022,44(5):1718-22. (in Chinese)
Yu XB, Qu XH. Evaluation on the therapeutic effect and safety of Sanqi Tongshu combined with edaravone in treating acute ischemic cerebral stroke. Guangming Journal of Chinese Medicine. 2022;37(22):4137-9. (in Chinese)
Ma JG. 81 cases of acute hemorrhagic stroke treated mainly with the combination of rhubarb and Panax notoginseng. Traditional Chinese Medicinal Research. 2009;22(1):33-4. (in Chinese)
Qi J. A systematic evaluation of the clinical efficacy of Sanqi preparations in the treatment of acute stroke [dissertation]. Beijing: Beijing University of Chinese Medicine; 2016. (in Chinese)
Shuhe BT. The clinical effects of Panax notoginseng in the treatment of patients with cardiovascular disease. Electronic Journal of Clinical Medical Literature. 2020;7(5):161-2. (in Chinese)
Hu LJ, Lan YJ, Qin W, Xiao P, Ning L, Zhou YY. Observation on the therapeutic effect of Yanghuo Sanqi capsules on coronary heart disease with yang deficiency and blood stasis type. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease. 2019;17(10):1513-5. (in Chinese)
Li Q, Ma L, Gao YM. Clinical effect of compound Xuesanqi capsule combined with pestle needle on cerebral atherosclerosis. Shanxi Medical Journal. 2020;49(22):3091-3. (in Chinese)
Xiao FP, Lin ZG. The therapeutic effect of traditional Chinese medicine application combined with Dida Damao pill and Sanqi capsule on closed ankle fracture combined with soft tissue injury. Chinese Journal of Clinical Rational Drug Use. 2024;17(3):117-20. (in Chinese)
Yang XH, Yang LS, Zheng DR. Observation on the therapeutic effect of compound Sanqi capsules combined with Dida pills in the treatment of orthopedic diseases. China Medical Herald. 2008;32(5):47-8. (in Chinese)
Chen T, Zhang SY, Liu QY. Clinical efficacy of Sanqi powder Chinese medicine enveloped for external application combined with voltaren emulsion in the treatment of ankle joints. Inner Mongolia Journal of Traditional Chinese Medicine. 2021;40(8):127-8. (in Chinese)
Qing TT, Guo YD, He F. Effects of Panax notoginseng powder and aspirin on platelet aggregation rate test results. Pharmacology and Clinics of Chinese Materia Medica. 2015;31(2):184-5. (in Chinese)
Wang P, Yan DM. The neuroprotection molecular basis and mechanism of Panax notoginseng saponins in the treatment of ischemic stroke. Chinese Pharmacological Bulletin. 2018;34(12):5. (in Chinese)
Yao Z, Liu DH, Ni XR. Clinical observation on improving circulatory stability during hemodialysis with Panax notoginseng capsules. Jiangxi Journal of Traditional Chinese Medicine. 2016;47(2):55-6. (in Chinese)
Ma GH. Clinical observation on the combined use of Panax notoginseng San and Panax notoginseng powder to prevent DVT after artificial knee replacement. Chinese Journal of Modern Drug Application. 2017;11(17):139-40. (in Chinese)
Liu SJ, Zou J. The effect of total saponins of Panax notoginseng on ischemia-reperfusion injury and hemorrhagic transformation in patients with acute ischemic stroke undergoing intravenous thrombolysis. Chinese Journal of Convalescent Medicine. 2021;30(6):656-7. (in Chinese)
Tian M. Yanghuo Sanqi capsules for the treatment of 60 cases of non-alcoholic fatty hepatitis combined with hyperlipidemia of Yang deficiency and blood stasis type. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases. 2016;26(4):239-40. (in Chinese)
Shi YX. Clinical study on Yanghuo Sanqi capsule in treating kidney hypertension of Yang deficiency and blood stasis type. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease. 2016;14(15):1790-2. (in Chinese)
Guo YX. Clinical observation on the treatment of type 2 diabetes mellitus combined with carotid atherosclerosis and blood stasis syndrome using Panax notoginseng powder [dissertation]. Beijing: Beijing University of Chinese Medicine; 2020. (in Chinese)